Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Operating Expenses | 58 | 179 | 843 | 3,759 | 1,666 |
| Operating Income | -58 | -179 | -843 | -3,759 | -1,666 |
| Interest Expense | 13 | 15 | 15 | 90 | 99 |
| Other Income | -30 | 14 | 21 | -24 | -6 |
| Pre-tax Income | -101 | -180 | -837 | -3,873 | -1,771 |
| Net Income Continuous | -101 | -180 | -837 | -3,873 | -1,771 |
| Net Income | $-101 | $-180 | $-837 | $-3,873 | $-1,771 |
| EPS Basic Total Ops | 0.00 | 0.00 | -32.26 | N/A | -64.52 |
| EPS Basic Continuous Ops | -2.27 | -4.03 | -18.75 | -104.17 | -48.40 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -32.26 | N/A | -64.52 |
| EPS Diluted Continuous Ops | -2.27 | -4.03 | -18.75 | -104.17 | -48.40 |
| EBITDA(a) | $-58 | $-179 | $-843 | $-3,617 | $-1,549 |